PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 21, 2015Epidemiology48 citations

Is the Risk Difference Really a More Heterogeneous Measure?

View Full Paper
CPCharlie PooleISIan ShrierTVTyler J. VanderWeele

Key Points

Key points are not available for this paper at this time.

Abstract

There are claims in the literature that the risk difference is a more heterogeneous measure than the odds ratio or risk ratio. These claims are based on surveys of meta-analyses showing that tests reject the null hypothesis of homogeneity more often for the risk difference than for the ratio measures. Discussions of this point have neglected the fact that homogeneity tests can have different levels of statistical power (i.e., different probabilities of rejecting the null when it is false) across different scales. We give hypothetical examples in which there is arguably equal heterogeneity across risk difference and odds ratio measures but in which the risk difference homogeneity test rejects more often, and therefore has higher power, than the odds ratio homogeneity test. These examples suggest that current empirical evidence for the claim that the risk difference is more heterogeneous is not at present satisfactory. Further research could consider other approaches to empirical comparisons of the heterogeneity of the three measures.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Poole et al. (2015) studied this question.

synapsesocial.com/papers/6a2006477ea8b8c49065a6bchttps://doi.org/10.1097/ede.0000000000000354
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinically useful measures of effect in binary analyses of randomized trials1994 · 274 citations
  2. 2CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials2010 · 3,896 citations
  3. 3Variability in Meta-analytic Results Concerning the Value of Cholesterol Reduction in Coronary Heart Disease: A Meta-Meta-Analysis1999 · 55 citations
  4. 4Sample size and optimal design for logistic regression with binary interaction2007 · 191 citations
  5. 5Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest2010 · 26 citations